skip to main content

Lindane Facts: The Truth About Lindane

Understanding Scabies and Lice

Incidence and Health Risks

Scabies and lice have no geographic boundaries nor do they discriminate by age, race, gender, or social class. Each affects millions of Americans and hundreds of millions of people worldwide. The incidence of these infectious conditions has increased steadily in recent decades, despite available treatments.1,2 If left undiagnosed. or poorly managed, scabies and lice can lead to more significant health risks and increased public health burden.

Scabies and lice are diseases of global proportion

Anyone can get scabies:

Some people are at greater risk for scabies:

Poor hygiene is not thought to be a factor in the spread of scabies7

The incidence of lice infestation has increased over the last three decades:2

Image of head lice infestation

Image of head lice infestation showing hair strands covered in “nits” or eggs. Severe itching and scratching can lead to bacterial infection and clumping of hair from fluid that weeps from the infected area.

Head lice and pubic (crab) lice are the most common forms in the U.S.:

Estimates of the incidence of lice infestation are likely low due to social stigma, self-treatment, and underreporting2,9

Scabies and lice can lead to other medical complications

Scabies complications can be serious:

* Please note that lindane is contraindicated for the treatment of crusted (Norwegian) scabies and should not be used for this condition.

Heavy lice infestation of the scalp with secondary abscess formation

Bite reactions and secondary infections can complicate lice infestations

References:

  1. Roos TC, Alam M, Roos S, et al. Pharmacotherapy of ectoparasitic infections. Drugs. 2001;61(8):1067–1088.
  2. Guenther L, Maguiness S, Austin TW. Pediculosis. 2005. Available at: http://www.emedicine.com/med/topic1769.htm.
  3. Chosidow O. Scabies and pediculosis. Lancet. 2000;355:819–826.
  4. Orion E, Matz H, Wolf R. Ectoparasitic sexually transmitted diseases: scabies and pediculosis. Clin Dermatol. 2004;22(6):513–519.
  5. Wendel K, Rompalo A. Scabies and pediculosis pubis: an update of treatment regimens and general review. Clin Infect Dis. 2002;35:S146–S151.
  6. U.S. Centers for Disease Control and Prevention (CDC). Parasitic Disease Information: Scabies Fact Sheet. 2005. Available at: http://www.cdc.gov/ncidod/dpd/parasites/scabies/factsht_scabies.htm.
  7. McCarthy JS, Kemp DJ, Walton SF, et al. Scabies: more than just an irritation. Postgrad Med J. 2004;80:382–387.
  8. West DP. Head lice treatment costs and the impact on managed care. Am J Manag Care. 2004;10(9 Suppl):S277–282.
  9. Hansen RC. Overview: the state of head lice management and control. Am J Manag Care. 2004;10(9 Suppl):S260–S263.
  10. Walton SF, McBroom J, Mathews JD, et al. Crusted scabies: a molecular analysis of Sarcoptes scabiei variety hominis populations from patients with repeated infestations. Clin Infect Dis. 1999;29:1226–1230.
  11. Wiederkehr M, Schwartz RA. Lice, scabies, and bedbugs. Best Practice of Medicine. October 2003. http://merck.micromedex.com/index.asp?page=bpm_report&article_id=BPM01DE11&section=report.
  12. Habif TP. Pediculosis. In: Clinical Dermatology, 4th edition. New York: Mosby; 2004:506–510.